Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Offers Common Stock; Hopes to Raise $12.6M

NEW YORK, April 23 (GenomeWeb News) - Bruker BioSciences hopes to raise $12.6 million in net proceeds from a public offering of 3 million shares of its common stock, the company said today.

 

The offering coincides with the sale of 12 million shares by four stockholders related to CEO Frank Laukien to the public, which is expected to generate $50.5 million in net proceeds.

 

The stock will be priced at $4.50 per share.

 

Bruker said it plans to use the proceeds for general corporate purposes, potential acquisitions, and possibly for the repayment of debt.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.